Overview

Update
Total Equity Funding
$5.1M in 2 Rounds from 5 Investors
Most Recent Funding
$3.3M Series B on May 13, 2014
Headquarters:
San Francisco, CA
Description:
Gemmus develops innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases.
Founders:
Categories:
Biotechnology
Website:
http://www.gemmuspharma.com

Company Details

Update

Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.

Funding Rounds (2) - $5.1M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2014$3.3M / Series B5
Jun, 2012$1.8M / Series A5

Current Team (2)

Update

Offices/Locations (1)

Update
  • Office

    409 Illinois Street, Suite 4004

    San Francisco, CA 94158

    USA

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos